HopeStage
Back to all studies
CompletedNCT00288366

Mood stabilizers, antipsychotics, and insulin resistance

About this titleRead the official source — NCT00288366
Medication studyAges 18–65United StatesSchizophrenia
The study in practice

Understand this study

Who was this study for?

Listed age limits: 18 years to 65 years.

Listed locations
NashvilleSee all locations and recruitment

Get this study by email

HopeStage may email me about this study.
Loading the security check...
Study clarity

Study information

Study start dateJanuary 2006
Recruitment status
Completed
Enrollment listed in the registry
49
Sponsor
Northwestern University
Sponsor type
University
Study type
Drug
Intervention type
Medication / drug
Study phase
Not clearly listed
Locations
United States
Age range
From 18 Years to 65 Years
Official registry ID
NCT00288366
Official title
Show the full official title

Anticonvulsant Mood Stabilizers, Antipsychotic Drugs and the Insulin Resistance Syndrome

Looking for a study you can join?

Explore recruiting studies

Recruitment & locations

Completed

Nashville

FAQ

Questions about this study

Who is behind this study?

The study sponsor is Northwestern University, a university.

Did this study involve medication?

Yes. The study involved medication, including ziprasidone vs. aripiprazole and aripiprazole vs. ziprasidone.

Who was this study for?

Listed age limits: 18 years to 65 years.

Want to explore more studies?

Explore studies